Replies to post #8907 on Hemispherx BioPharma (HEB)

[LasNubes]

That's very interesting. Thanks for posting it.
As I was reading the transcript I got the feeling that the FDA panel really is looking at this from a very different perspective.
They seem to be getting the message that we have a lot of patients without any viable treatment options. Ampligen has been used successfully for many years in selected patients without serious risk. The risk to benefit ratio would seem to favor approval this time around!